Cartalax ge 'nar péptido sintético ar cadena corta ko ar secuencia aminoácidos Ala — Glu — Asp. Derivado ja 'nar fragmento proteína xi 'mui mbo cartílago sano, ge 'nar molécula sintética cuidadosamente diseñada.
Ar secuencia específica aminoácidos imita ya ya endógenos moléculas señalización; Unión ma ciertos receptores celulares, 'nar cascada 'mefa ár njäts'i Tange'u nthädi celulares.
Diseño sintético racional concede ar Cartalax mextha nt'ot'e biológica, Especificidad, Xí hñets'i'i inmunogenicidad, ne hño absorción transdérmica wa oral.
nthoni jar continua detalla ár multi — dirigida, multi za̲ ár nthe̲ integral 'ba̲ts'i ne ár hne reparativa.
Supresión xi hño ar inflamación ge 'na nuna ar resultado – Ntsuni abajo ar citocinas proinflamatorias inducida Matrix metaloproteinases (MMPs) ne ADAMTS komongu ya mecanismos primarios; Erosión directa ne degradación colágeno klase II ne varios proteoglicanos ar mitigan, cartílago articular 'mui estructural ar preservando.
mejorando mfeni regenerativa ar extracellular matrix ge gi 'ñu nt'ot'e sugerida ya nsadi mäs recientes; condrocito marcadores específicos ar regulan jar mañä ne ár síntesis promue.
ngi cartílago menor to da reparado a través de nuya nt'ot'e, saludable homeostasis s.
antiinflamatorio, propiedades inmunomoduladoras ne antienvejecimiento ya nga̲tho 'nar xe̲ni ar perfil Cartalax; ensayos clínicos 'bu̲'bya exploran ga̲tho nä'ä 'be̲t'o.
Síntesis ne nt'ot'e Cartalax o̲t'e 'nar prometedora 'mui terapia peptídica bioactiva.
Secuencia
Ala — Glu — Asp
'bede ya CAS
/
Fórmula molecular
C12H19N3O8
Be̲xu molecular
333.297
Nthoni ar péptido Cartalax
1.inhibición ar cartílago Catabolismo
Honja hmä, prevención ar degradación excesiva ge jar núcleo nga̲tho ár nthoni basada ar Cartalax.
anormal factor pro inflamatorio señalización da to interrumpida, and the enzymes responsible for degrading the matrix (again, primarily MMPs/Matrix Metalloproteinases) either directly or indirectly inhibited.
Mechanical integrity of cartilage tissue is the end point of all this work.
2.promocionando Cartilage Síntesis
Cartalax also demonstrates an exceptional capacity to enhance tissue anabolic metabolism.
Upregulating condrocito functional activity, it rapidly increases the synthesis and subsequent secretion of various extracellular matrix components; direct cartilage formation is the primary end result of this process.
In vitro studies have confirmed this effect – treated chondrocytes or stem cells show significantly elevated gene expression levels of type II collagen and aggrecan, with corresponding increases in the actual production of said proteins.
Further indirect enhancement of cellular metabolism and protein synthesis are achieved through specific intracellular signaling pathways (TGF-β/Smad being a prime example); tissue regeneration is the desired outcome.
Repairing pre-existing microdamage and constructing a functional matrix are two valuable pathways enabled by this line of action.
3.Anti-inflammatory and Immunomodulatory Effects
NF — κB serves as a key signal for activating numerous inflammatory factors.
Cartalax actively suppresses, or at least reduces, NF-κB expression – hitting the source of most inflammatory responses.
Pain, swelling and the more permanent stiffness associated with inflammation are all effectively alleviated.
The cartilage protective effects described above are intrinsically part of this anti-inflammatory process; reducing inflammation is a fundamental aspect of Cartalax’s overall mechanism of action.
COA
HPLC
MS
